PCM
AGN.PRA

Pentwater Capital Management’s Allergan plc AGN.PRA Stock Holding History

Pentwater Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-10,000
Closed -$10.5M – 175
2015
Q2 		$10.5M Buy
+10,000
New +$10.5M 0.06% 98

Other funds holding AGN.PRA

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Pentwater Capital Management's AGN.PRA Position: Q3 2015 in Review

Pentwater Capital Management sold out of Allergan plc (AGN.PRA) in Q3 2015, closing a stake of 10,000 shares — an estimated $10.5M sold.

Pentwater Capital Management first reported a position in AGN.PRA in Q2 2015 and held it in 1 quarter. The position peaked at $10.5M in Q2 2015. 99 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2015.

  • Pentwater Capital Management reported no remaining Allergan plc position as of Q3 2015 after selling out during the quarter.
  • Pentwater Capital Management sold 10,000 Allergan plc shares in Q3 2015, an estimated $10.5M.
  • Pentwater Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 1 quarter.
  • Pentwater Capital Management's Allergan plc position peaked at $10.5M in Q2 2015.
  • 99 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on Pentwater Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.